Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$20,577,126
in 17 filings, $20.2M under 10b5-1 plans

Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-09-18 Wheeler Patrick M Chief Financial Officer Sale −8,246 $1.31 $11K 101,510
2014-02-27 Wheeler Patrick M Chief Financial Officer Grant or award +34,200 $1.95 $67K 109,756
2014-02-27 Wheeler Patrick M Chief Financial Officer Grant or award · Stock Option (right to buy) +20,500 20,500
2013-09-17 Wheeler Patrick M Chief Financial Officer Grant or award +75,000 $1.38 $104K 75,556
2013-09-17 Wheeler Patrick M Chief Financial Officer Grant or award · Stock Option (right to buy) +81,856 81,856
2011-05-20 Wheeler Patrick M Chief Financial Officer Grant or award · Options to Purchase Common Stock −20,000 20,000
2010-02-18 Wheeler Patrick M acting Chief Financial Officer Grant or award · Option to Purchase Common Stock +6,400 6,400

Page 1 of 1 · 7 trades